Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

UnitedHealthcare Coverage for Oxbryta (Voxelotor) in Washington: 2024 FDA Withdrawal and Alternative Options

Answer Box: Oxbryta Coverage Status Oxbryta (voxelotor) is no longer available and cannot be covered by UnitedHealthcare or any insurer. Pfizer voluntarily withdrew the drug in September 2024 following FDA safety review. Your fastest path forward: Work with your hematologist to transition to FDA-approved alternatives like hydroxyurea, L-glutamine, or crizanlizumab.
5 min read

ICD-10 Codes and Billing Guide: Getting Xenpozyme Covered by UnitedHealthcare in Florida

Answer Box: Getting Xenpozyme Covered by UnitedHealthcare in Florida Quick Path to Approval: Xenpozyme requires prior authorization through UnitedHealthcare with specific ICD-10 codes (E75.240-E75.244), genetic testing confirmation, and medical benefit billing. Submit via OptumRx at 1-833-547-2030 with complete clinical documentation including ASMD diagnosis confirmation, baseline spleen imaging, and
7 min read

Do You Qualify for Sylvant (Siltuximab) Coverage by UnitedHealthcare in Michigan? Complete Decision Tree & Appeals Guide

Answer Box: Your Path to Sylvant Coverage in Michigan Quick eligibility check: You likely qualify for Sylvant (siltuximab) coverage if you have confirmed idiopathic multicentric Castleman disease (iMCD), are HIV-negative and HHV-8-negative, and meet basic lab thresholds. UnitedHealthcare requires prior authorization through their provider portal, typically taking 1-5 business days.
6 min read

How to Get Pomalyst (Pomalidomide) Covered by UnitedHealthcare in Illinois: Complete PA Guide with Appeal Forms and Timelines

Answer Box: Getting Pomalyst Covered by UnitedHealthcare in Illinois Fastest Path to Approval: Pomalyst (pomalidomide) requires prior authorization from UnitedHealthcare. Your oncologist must submit clinical documentation showing you've tried and failed both lenalidomide and a proteasome inhibitor, with disease progression within 60 days of last therapy. Illinois banned
6 min read

If Darzalex Isn't Approved by UnitedHealthcare in Washington: Formulary Alternatives & Exception Paths

Answer Box: When Darzalex Isn't Your First Option If UnitedHealthcare denies Darzalex (daratumumab) in Washington, you have proven alternatives and exception paths. Fastest approach: Try formulary alternatives like Sarclisa (isatuximab) or proteasome inhibitors first, document response/failure thoroughly, then request a Darzalex exception with clinical evidence. Start today:
6 min read